Tag Archives: Novo

Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal  The Wall Street Journal Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid  Reuters Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian  BioSpace Pfizer sues to stop rival bid for drugmaker Metsera by Denmark’s Novo Nordisk  Yahoo Finance Pfizer Races to Save Obesity Drugmaker Deal After Novo’s Bid  Bloomberg …

As The Beatles once sang, we all need a little bit of help from our friends. So, according to Reuters, it might not come as a huge surprise if U.S. drug giant Pfizer (PFE) uses its connections with President Trump to win an $8.5 billion bidding war with Danish rival Novo Nordisk (NVO) over obesity-fighting biotech Metsera (MTSR). Elevate Your …

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — A bidding war has broken into the open for obesity-focused Metsera, with Novo Nordisk on Thursday saying it had made an offer for the biotech, a month after Pfizer announced its plan to purchase the firm.  The Novo offer, …

Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera  The Wall Street Journal European markets negative; Novo Nordisk drops 3% after surprise bid for Metsera  CNBC Novo Nordisk bid for obesity-focused biotech firm could gazump Pfizer offer  The Guardian Novo Offers $6.5 Billion for Metsera to Challenge Pfizer  Bloomberg.com Metsera says Novo Nordisk’s $9B buyout offer “superior”; Pfizer calls bid “illusory” …

Novo Nordisk enters bidding war with Pfizer over US biotech Metsera  Reuters Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera  Yahoo Finance Novo Offers $6.5 Billion for Metsera to Challenge Pfizer  Bloomberg Novo Nordisk hijacks Pfizer with bid for U.S. biotech Metsera  CNBC Novo Nordisk submits proposal to acquire Metsera, Inc.  GlobeNewswire Source link

The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen outside theri building as the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Several Novo Nordisk board members will step down from their positions after …

The company behind weight-loss jab Wegovy and diabetes drug Ozempic will have a boardroom clear-out, with seven board members including the chairman set to depart. Novo Nordisk on Tuesday said chairman Helge Lund, vice chair Henrik Poulsen and five directors will not stand for re-election at an extraordinary investor meeting in November. The departures came about after a disagreement between …

Novo Nordisk’s Entire Board Is Stepping Down in a Surprise Move. Here’s Why.  Barron’s Wegovy maker’s board shaken up as directors quit  BBC Novo Nordisk chair and directors quit after boardroom rift  CNBC Novo Nordisk’s top investor seizes board control in weight-loss drug battle  Reuters Novo Nordisk chair and six directors exit after dispute with shareholder  Financial Times Source link

Novo Nordisk’s top investor seizes board control in weight-loss drug battle  Reuters Wegovy maker’s board shaken up as directors quit  BBC Novo Nordisk chair and directors quit after boardroom rift  CNBC Novo Chairman to Step Down in Shakeup After Rift on Board  Bloomberg Novo Nordisk to Shake Up Board After Obesity-Market Challenges  The Wall Street Journal Source link

Novo GLP-1 pill OK’d in U.S. for heart disease risk (NVO:NYSE)  Seeking Alpha FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk  The Wall Street Journal First oral GLP-1 cuts cardiovascular risk by 14% – and it’s now FDA-approved  New Atlas FDA approves Novo Nordisk’s oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at …